Neoadjuvant chemotherapy for advanced ovarian cancer

被引：4
|
作者：
Eisenkop, SM
Spirtos, NM
Friedman, RL
机构：
[1] Womens Canc Ctr Encino, Tarzana, CA 91356 USA
[2] Womens Canc Ctr, Palo Alto, CA 94304 USA
来源：
GYNECOLOGIC ONCOLOGY | 1999年 / 74卷 / 02期
关键词：
D O I：
10.1006/gyno.1999.5529
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [41] Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer
    Matsuo, Koji
    Matsuzaki, Shinya
    Nusbaum, David J.
    Maoz, Asaf
    Oda, Katsutoshi
    Klar, Maximilian
    Roman, Lynda D.
    Sood, Anil K.
    GYNECOLOGIC ONCOLOGY, 2021, 160 (01) : 32 - 39
  • [42] NEOADJUVANT CHEMOTHERAPY AND INTERVAL DEBULKING FOR ADVANCED EPITHELIAL OVARIAN-CANCER
    JACOB, JH
    GERSHENSON, DM
    MORRIS, M
    COPELAND, LJ
    BURKE, TW
    WHARTON, JT
    GYNECOLOGIC ONCOLOGY, 1991, 42 (02) : 146 - 150
  • [43] Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: An institutional experience.
    Jain, Kavitha
    Chaturvedi, Arun
    Misra, Sanjeev
    Kumar, Vijay
    Gupta, Sameer
    Lakshmanan, Manikandan
    Garg, Sudeep
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
    Schwartz, PE
    Rutherford, TJ
    Chambers, JT
    Kohorn, EI
    Thiel, RP
    GYNECOLOGIC ONCOLOGY, 1999, 72 (01) : 93 - 99
  • [45] Investigation of the timing of neoadjuvant chemotherapy on survival in advanced stage ovarian cancer
    Buechel, M. E.
    Mahdi, H.
    Rose, P. G.
    Michener, C.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 146 - 147
  • [46] Neoadjuvant chemotherapy in advanced-stage ovarian cancer - state of the art
    Margioula-Siarkou, Chrysoula
    Petousis, Stamatios
    Papanikolaou, Alexios
    Gullo, Giuseppe
    Margioula-Siarkou, Georgia
    Lagana, Antonio Simone
    Dinas, Konstantinos
    Guyon, Frederic
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2022, 21 (04): : 272 - 275
  • [47] Rate of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer
    Salinaro, J. R.
    Boccaccio, R. B.
    Ehrisman, J. A.
    Havrilesky, L. J.
    Secord, A. A.
    Moore, K. N.
    Davidson, B. A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 29 - 30
  • [48] Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy
    Sato, Seiya
    Itamochi, Hiroaki
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (06) : 293 - 304
  • [49] Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer
    Fleming, Nicole D.
    Westin, Shannon N.
    Rauh-Hain, J. Alejandro
    Soliman, Pamela T.
    Fellman, Bryan M.
    Coleman, Robert L.
    Meyer, Larissa A.
    Shafer, Aaron
    Cobb, Lauren P.
    Jazaeri, Amir
    Lu, Karen H.
    Sood, Anil K.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (01) : 65 - 71
  • [50] Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer
    Vergote, IB
    De Wever, I
    Decloedt, J
    Tjalma, W
    Van Gramberen, M
    van Dam, P
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : 31 - 36
12345